中文名 | p38 MAP激酶抑制剂V |
---|---|
英文名 | 4-[3-(4-chlorophenyl)-5-(1-methylpiperidin-4-yl)-1H-pyrazol-4-yl]pyrimidine |
英文别名 |
5-(N-METHYL-4-PIPERIDYL)-4-(4-PYRIMIDYL)-3-(4-CHLOROPHENYL)PYRAZOLE
p38 MAP Kinase Inhibitor V |
分子式 | C19H20ClN5 |
---|---|
分子量 | 353.84900 |
精确质量 | 353.14100 |
PSA | 57.70000 |
LogP | 3.93420 |
~% 271576-77-3 |
文献:G.D. Searle and Company Patent: US6514977 B1, 2003 ; US 6514977 B1 |
~% 271576-77-3 |
文献:Walker, John K.; Selness, Shaun R.; Devraj, Rajesh V.; Hepperle, Michael E.; Naing, Win; Shieh, Huey; Kurambail, Ravi; Yang, Syaulan; Flynn, Daniel L.; Benson, Alan G.; Messing, Dean M.; Dice, Tom; Kim, Tina; Lindmark; Monahan, Joseph B.; Portanova, Joseph Bioorganic and Medicinal Chemistry Letters, 2010 , vol. 20, # 8 p. 2634 - 2638 |
上游产品 1 | |
---|---|
下游产品 0 |